FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.
Source: Cnbc.com
Original source: https://www.cnbc.com/2026/03/18/icotyde-psoriasis-pill-from-jj-to-rival-tremfya-skyrizi-il-23-shots.html
Similar Posts
Justo Hidalgo, doctor en Ciencia de Datos: “Existen capacidades que surgen de la IA a partir de cierta complejidad y son impredecibles”
Get Paid To Use Facebook, Twitter and YouTube M.S.S – Member area and video courses From our network The Best Upright Freezer of 2026: Your Ultimate Buying Guide The Ultimate Guide to the Best Upright Freezers of 2026 The Ultimate Guide to the Best Upright Freezers of 2026 The Ultimate Guide to the Best Upright…
New Ideas Emerge to End Gaza Conflict and Govern After War
Kerassentials Deliverable GPT Creator Club From our network The Best Upright Freezer of 2026: Your Ultimate Buying Guide The Ultimate Guide to the Best Upright Freezers of 2026 The Ultimate Guide to the Best Upright Freezers of 2026 The Ultimate Guide to the Best Upright Freezers of 2026 The Ultimate Guide to the Best Upright…
